Paloma Partners Management CO Rigel Pharmaceuticals Inc Transaction History

Paloma Partners Management CO

  • $3.08 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$2.35 - $3.74 $55,260 - $87,946
-23,515 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$1.78 - $4.13 $41,856 - $97,116
23,515 New
23,515 $56,000
Q1 2020

May 15, 2020
SELL
$1.27 - $3.0 $14,386 - $33,984
-11,328 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$1.6 - $2.43 $33,235 - $50,475
-20,772 Reduced 64.71%
11,328 $24,000
Q3 2019

Nov 14, 2019
BUY
$1.63 - $2.62 $52,323 - $84,102
32,100 New
32,100 $60,000

Others Institutions Holding RIGL

# of Institutions
8
Shares Held
334K
Call Options Held
0
Put Options Held
0
View Full List

About RIGEL PHARMACEUTICALS INC

RIGL Quotes by TradingView
  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $4.17B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email